WHO ICTRP trial
A study to assess how effective and safe is the moisturizer for patients having…
CTRI/2019/07/020458 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2019/07/020458 |
|---|---|
| Public title | A study to assess how effective and safe is the moisturizer for patients having acne who are prescribed isotretinoin |
| Scientific title | AN OPEN LABEL, OBSERVATIONAL, PROSPECTIVE, NON-COMPARATIVE, MULTICENTRE STUDY TO EVALUATE EFFECTIVENESS AND TOLERABILITY OF MOISTURISER IN ACNE PATIENTS WHO ARE PRESCRIBED ISOTRETINOIN - Complement |
| Primary sponsor | Cipla Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | PMS |
| Phase | Post Marketing Surveillance |
| Countries | India |
| Conditions | Health Condition 1: L988- Other specified disorders of the skin and subcutaneous tissue |
| Interventions | Intervention1: Moisturizer(Excela): 28 days+_ 2 days Moisturizer(Excela) application along with anti acne treatment of Isotretinoin. |
| Registration date | Jul 31, 2019 |
| Target size | 200 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: